Novartis' cancer treatment Kymriah gets Japan nod at cost of $305,800

México Noticias Noticias

Novartis' cancer treatment Kymriah gets Japan nod at cost of $305,800
México Últimas Noticias,México Titulares
  • 📰 Reuters
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

A Japanese government panel approved Novartis' cancer treatment Kymriah at ...

FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018. REUTERS/Arnd Wiegmann/File Photo

The Swiss drugmaker aims to use the one-time personalized therapy in Japan for children and young people with acute lymphoblastic leukemia and adult patients with diffuse large B-cell lymphoma .

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Reuters /  🏆 2. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Justice Ruth Bader Ginsburg gets 'best fight' MTV Movie award nodJustice Ruth Bader Ginsburg gets 'best fight' MTV Movie award nodU.S. Supreme Court Justice Ruth Bader Ginsburg scored nominations on Tuesday for...
Leer más »

Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competitionLawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competitionThe complaint names drugmakers Bristol-Myers Squibb and Johnson & Johnson subsidiary Janssen Pharmaceuticals as co-defendants.
Leer más »

Stocks making the biggest moves premarket: Disney, Intel, Etsy, Fox Corp, Costco, Novartis & moreSome of the names on the move ahead of the open.
Leer más »

Novartis buys Takeda's dry eye drug for $3.4 billionNovartis buys Takeda's dry eye drug for $3.4 billionSwiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharma...
Leer más »

Takeda sells dry eye drug to Novartis to help cut debtTakeda sells dry eye drug to Novartis to help cut debtTakeda Pharmaceutical Co Ltd agreed to sell its dry eye drug to Swiss drugmaker ...
Leer más »

Novartis vows to fight U.S. price-fixing claims against Sandoz unitNovartis vows to fight U.S. price-fixing claims against Sandoz unitNovartis on Monday said claims of price fixing against its Sandoz generics unit ...
Leer más »

Brazil government, central bank nod to rapidly deteriorating GDP, fiscal positionBrazil government, central bank nod to rapidly deteriorating GDP, fiscal positionBrazil's government and central bank said the country's economic and f...
Leer más »

Electronic implants studied for treatment of drug additionElectronic implants studied for treatment of drug additionSHANGHAI (AP) — Patient Number One is a thin man, with a scabby face and bouncy knees. His head, shaved in preparation for surgery, is wrapped in a clean, white cloth. Years of drug use cost...
Leer más »

David Ortiz says he wouldn't visit White House because of Trump's treatment of immigrantsDavid Ortiz says he wouldn't visit White House because of Trump's treatment of immigrants'You don’t want to go and shake hands with a guy who is treating immigrants like (expletive),' Big Papi said.
Leer más »



Render Time: 2025-03-01 20:49:02